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Abstract
BACKGROUND 
Periodontitis is a chronic inflammation of periodontal tissues. The effect of 
periodontitis on the development of inflammatory bowel disease (IBD) remains 
unclear.
AIM 
To assessed the risk of IBD among patients with periodontitis, and the risk factors 
for IBD related to periodontitis.
METHODS 
A nationwide population-based cohort study was performed using claims data 
from the Korean National Healthcare Insurance Service. In total, 9950548 
individuals aged ≥ 20 years who underwent national health screening in 2009 
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were included. Newly diagnosed IBD [Crohn’s disease (CD), ulcerative colitis 
(UC)] using the International Classification of Disease 10th revision and rare 
intractable disease codes, was compared between the periodontitis and non-
periodontitis groups until 2017.
RESULTS 
A total of 1092825 individuals (11.0%) had periodontitis. Periodontitis was 
significantly associated with older age, male gender, higher body mass index, 
quitting smoking, not drinking alcohol, and regular exercise. The mean age was 
51.4 ± 12.9 years in the periodontitis group and 46.6 ± 14.2 years in the non-
periodontitis group (P < 0.01), respectively. The mean body mass index was 23.9 ± 
3.1 and 23.7 ± 3.2 in the periodontitis and non-periodontitis groups, respectively (
P < 0.01). Men were 604307 (55.3%) and 4844383 (54.7%) in the periodontitis and 
non-periodontitis groups, respectively. The mean follow-up duration was 7.26 
years. Individuals with periodontitis had a significantly higher risk of UC than 
those without periodontitis [adjusted hazard ratio: 1.091; 95% confidence interval 
(CI): 1.008-1.182], but not CD (adjusted hazard ratio: 0.879; 95% confidence 
interval: 0.731-1.057). The risks for UC were significant in the subgroups of age ≥ 
65 years, male gender, alcohol drinker, current smoker, and reduced physical 
activity. Current smokers aged ≥ 65 years with periodontitis were at a 1.9-fold 
increased risk of UC than non-smokers aged ≥ 65 years without periodontitis.
CONCLUSION 
Periodontitis was significantly associated with the risk of developing UC, but not 
CD, particularly in current smokers aged ≥ 65 years.
Key Words: Inflammatory bowel disease; Periodontitis; Smoking; Ulcerative colitis; 
Crohn’s disease
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Core Tip: We evaluate the impact of periodontitis on the development of ulcerative colitis 
(UC) using the nationwide population-based cohort data. In total, 9950548 individuals 
undergoing national health screenings in 2009 were included in this study and were 
followed for an average of 7.26 years. Patients with periodontitis had a higher risk of UC 
than those without periodontitis. Current smokers over 65 years with periodontitis were at 
a 1.9-fold increased risk of UC than non-smokers without periodontitis. Periodontitis was 
significantly associated with the risk of UC and cigarette smoking could superimpose the 
impact of periodontitis on UC, especially in elderly people.
Citation: Kang EA, Chun J, Kim JH, Han K, Soh H, Park S, Hong SW, Moon JM, Lee J, Lee 
HJ, Park JB, Im JP, Kim JS. Periodontitis combined with smoking increases risk of the 




Periodontitis is a chronic infectious and inflammatory disease of periodontal tissues 
caused by interactions between the microbiota in the root canals and the host immune 
system[1]. Periodontitis can be caused by a variety of etiologies, such as alveolar bone 
destruction, dental plaque bacteria, remnant food material, and an abnormal immune 
response[2]. The prevalence of periodontitis ranges from 20% to 50% globally and 
increases with age[3,4]. Risk factors for periodontitis, such as smoking and alcohol 
consumption, diabetes mellitus, obesity, and metabolic syndrome, have been reported 
in previous studies[5,6]. Furthermore, periodontitis is closely linked to the pathogenesis 
of systemic disease[7,8].
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative 
colitis (UC) are chronic relapsing inflammatory diseases of the gastrointestinal tract 
with many causes. Complex interactions among gut dysbiosis, changes in the host 
Kang EA et al. Impact of periodontitis and smoking on UC
WJG https://www.wjgnet.com 5663 October 7, 2020 Volume 26 Issue 37
immune system, and genetic factors affect the development of IBD. In Asia, the 
prevalence of IBD is rapidly increasing, and its genetic predisposition and 
environmental impact is different from that of western countries[9]. Environmental 
factors such as smoking and alcohol consumption can be associated with the 
development of IBD. The effects of smoking on the pathogenesis of CD and UC are 
different. Smoking may have a minor role in the development of CD in Asia, unlike 
western populations[10]. In contrast, former smokers have a significantly higher risk of 
developing UC than non-smokers[11]. Alcohol consumption is related to exacerbation of 
symptoms in patients with IBD[12].
The destruction of periodontal tissues might induce activation of a variety of 
cytokines related to the pathophysiology of IBD[13]. In addition, changes in the gut 
microbiota and immunosuppressive agents used to treat IBD can deteriorate oral 
health via changes in the oral microbiota, resulting in an increased risk for 
periodontitis[14,15]. Periodontitis and IBD are characterized by chronic inflammation 
initiated in the oro-intestinal tract, and share a number of similar pathophysiological 
features. However, the pathogenic relationship between periodontitis and IBD remains 
unclear. Epidemiological studies regarding the effects of periodontitis based on age 
and environmental factors on the occurrence of IBD are lacking. The aims of the study 
were to assess the incidence and risk of IBD among patients with periodontitis and 
identify the risk factors for the occurrence of IBD related to periodontitis.
MATERIALS AND METHODS
Database
The National Health Insurance (NHI) service is a single, mandatory medical insurer 
providing a health insurance to approximately 51 million citizens in South Korea. The 
NHI database contains information on comorbidities, drug prescriptions, treatment, 
and demographic characteristics of Koreans due to the unique nature of the NHI 
service. The National Health Screening Program (NHSP) is conducted every 2 years 
for all qualified adults > 20 years of age, and the information collected by the NHSP 
accumulates as a separate cohort. Clinical data at baseline and trends in changes in the 
data can be evaluated in the cohort. The Rare and Intractable Diseases (RID) system 
supports additional medical costs for patients with RIDs, such as IBD. We identified 
the RIDs with a special diagnostic code (V code). CD is a rare disease, and UC is 
regarded as an intractable disease in South Korea.
Study population
This was a nationwide population-based retrospective cohort study using the NHI 
claims data from a population who underwent the NHSP in 2009 (index year). Patients 
were classified into the periodontitis group when the International Classification of 
Diseases (ICD)-10 code for periodontitis (K05.3) was identified at the index 
examination. The periodontitis group was divided into three stages according to the 
severity of periodontitis based on therapeutic procedures, including scaling, sub-
gingival curettage, and surgery. Individuals without periodontitis were considered the 
non-periodontitis group. In both groups, patients who were diagnosed with IBD from 
2004 to 2009 were excluded to rule out IBD cases not related to periodontitis (washout 
period). Newly diagnosed IBD patients in the first year after the index year were also 
excluded (lag period). Patients who were newly diagnosed with periodontitis during 
the follow-up period in the non-periodontitis group were censored in this study.
Definition and data acquisition
Age, sex, body mass index (BMI), waist circumference, cigarette smoking, alcohol 
drinking, exercise, income, comorbidities, and laboratory findings were collected in 
the periodontitis and non-periodontitis groups. Smoking was classified as current 
smoker, ex-smoker, and nonsmoker based on a questionnaire[11]. Current smokers were 
defined as those who had smoked more than five packs of cigarettes throughout their 
lives and continued cigarette smoking. Ex-smokers were defined as those who had 
smoked more than five packs of cigarettes but quit smoking at least 1 mo ago. Non-
smokers were defined as those who had no experience with cigarette smoking or had 
smoked less than five packs throughout their lifetime. Alcohol drinking was 
categorized into non-drinker, mild, and excessive drinker. The excessive drinker was 
defined as consuming more than 30 g per day of alcohol[16]. Exercise was considered 
‘yes’ according to the questionnaire when the participant performed moderate-
intensity exercise for 30 min or vigorous-intensity exercise for 20 min at least once per 
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week[17]. Obesity was defined as BMI > 25 kg/m2, and central obesity was defined as a 
waist circumference > 90 cm in males and > 85 cm in females. Hypertension was 
defined as blood pressure ≥ 140/90 mmHg, or ICD-10 code (I10-13, I15) and a 
prescription for anti-hypertensive medication[18,19]. Diabetes was identified using an 
ICD-10 code (E11-14) and anti-diabetic medication or fasting glucose levels ≥ 126 
g/dL[16]. Dyslipidemia was defined using ICD-10 code (E78) and taking one of the 
lipid-lowering agents, or a total cholesterol level ≥ 240 mg/dL. Laboratory data, 
including serum glucose, total cholesterol, gamma glutamyltransferase and 
triglyceride levels, were also collected.
End points
The study population was followed up from the index date to December 31, 2017. 
Newly diagnosed IBD was the study endpoint. IBDs, including CD and UC were 
identified with the ICD-10 code (K50 for CD and K51 for UC) and the V code for RIDs 
(V130 for CD and V131 for UC), as defined previously[11,16,18-25]. The risk for IBD was 
compared between the periodontitis and non-periodontitis groups, according to age, 
sex, smoking, alcohol drinking, exercise, obesity, and central obesity. In addition, we 
investigated the specific risk groups for developing UC in a subgroup analysis. This 
study was approved by International Review Board of Seoul National University 
Hospital (H-1703-107-840) and the Korean NHI.
Statistical analysis
Base characteristics of study population were analyzed by χ2 test for categorical 
variables and Student’s t-test for continuous variables. The incidence rate was 
represented by incident cases of IBD per 100000 person-years. Cumulative incidence 
probability of CD and UC was shown using Kaplan-Meyer methods and the log-rank 
test. Hazard ratio (HR) of CD and UC in the periodontitis and non-periodontitis 
groups was calculated using Cox-proportional hazard models adjusted by age, sex, 
smoking, alcohol drinking, exercise, BMI, and income. A P value less than 0.05 is 
considered significant. SAS version 9.3 (SAS Institute, Cary, NC, United States) was 
used for statistical analyses.
RESULTS
Baseline characteristics of the study population
A total of 9950548 participants were included in this study. Among them, 1092825 
subjects (11.0%) had periodontitis. The demographic characteristics and baseline 
laboratory profile are shown in Table 1. Mean age was 51.4 ± 12.9 years in the 
periodontitis group and 46.6 ± 14.2 years in the non-periodontitis group, respectively (
P < 0.0001). The periodontitis group was significantly older, had a higher proportion of 
males, and a higher BMI and waist circumference than those in the non-periodontitis 
group (P < 0.0001 for each variable). Patients with periodontitis had significantly 
higher proportions of individuals quitting smoking, not drinking alcohol, but 
performing regular exercise, compared with the non-periodontitis group (P < 0.0001 
for each variable). Comorbid hypertension and diabetes were significantly associated 
with periodontitis (P < 0.0001 for each variable). Serum glucose, total cholesterol, 
gamma glutamyltransferase, and triglyceride levels were significantly higher in the 
periodontitis group than the non-periodontitis group (P < 0.0001 for each variable).
Risk of developing IBD
The mean follow-up duration was 7.26 ± 0.76 years. The incidence rate values of UC 
represented by newly diagnosed cases per 100000 person-years were 7.1 and 7.7 in the 
non-periodontitis and periodontitis groups, respectively (Table 2). The cumulative 
incidence of UC was significantly higher in the periodontitis group than in the non-
periodontitis group (P < 0.0001) (Figure 1). The HR of UC adjusted for age, sex, BMI, 
smoking, alcohol drinking, exercise, and income was 1.091 [95% confidence interval 
(CI): 1.008–1.182] in the periodontitis group. However, periodontitis did not increase 
the risk of CD compared with not having periodontitis (adjusted HR: 0.879; 95%CI: 
0.731–1.057). The HRs of UC and CD in the periodontitis group did not differ 
significantly from those in the non-periodontitis group (data not shown).
Subgroup analysis
A subgroup analysis of the comparative risk for developing UC and CD was 
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Table 1 Baseline characteristics of the study population
Periodontitis Non-periodontitis P value
Patients, n 1092825 8857723
Age, yr (mean ± SD) 51.4 ± 12.9 46.6 ± 14.2 < 0.01
Age, 3 groups (%) < 0.01
20-39 188805 (17.2) 2929998 (33.1)
40-64 719197 (65.8) 4810132 (54.3)
≥ 65 184823 (16.9) 1117593 (12.6)
Male (%) 604307 (55.3) 4844383 (54.7)
BMI, kg/m2 (mean ± SD) 23.9 ± 3.1 23.7 ± 3.2 < 0.01
Waist circumference, cm (mean ± SD) 81.2 ± 8.8 80.1 ± 9.1 < 0.01
Cigarette smoking (%) < 0.01
Nonsmoker 644790 (59.0) 5276142 (59.6)
Ex-smoker 188825 (17.3) 1238268 (14.0)
Current smoker 259210 (23.7) 2343313 (26.4)
Drinking (%) < 0.01
Non 597901 (54.7) 4528675 (51.1)
Mild 423429 (38.8) 3718,835 (42.0)
Heavy 71495 (6.5) 610213 (6.9)
Exercise; yes (%) 572684 (52.4) 4544197 (51.3) < 0.01
Income; low (less than 20% of total population) (%) 274356 (25.1) 2347661 (26.5) < 0.01
Underlying illness < 0.01
Hypertension (%) 338855 (31.0) 2220906 (17.8)
Systolic BP, mmHg (mean ± SD) 123.1 ± 15.0 122.3 ± 14.9
Diastolic BP, mmHg (mean ± SD) 76.6 ± 10.0 76.3 ± 10.0
Dyslipidemia (%) 244342 (22.4) 1574251 (17.8)
Diabetes (%) 131663 (12.1) 734481 (8.3)
Initial laboratory findings
Glucose, mg/dL (mean ± SD) 99.6 ± 25.3 96.8 ± 22.6 < 0.01
Total cholesterol, mg/dL (mean ± SD) 196.8 ± 37.0 191.7 ± 35.4 < 0.01
GGT, IU/L (median and 95%CI) 28.5 (28.4–28.6) 27.4 (27.4–27.42) < 0.01
Triglycerides, mg/dL (median and 95%CI) 117.9 (117.7–117.9) 113.2 (113.1–113.2) < 0.01
SD: Standard deviation; BMI: Body mass index; BP: Blood pressure; GGT: Gamma glutamyltransferase; CI: Confidence interval.
performed based on age, sex, alcohol drinking, cigarette smoking, and exercise 
(Figure 2A and B). We compared the risk of developing UC between the periodontitis 
and non-periodontitis groups by dividing the two groups into three subgroups 
according to age: < 40 years, 40-64 years, and > 65 years. The significant comparative 
risk of developing UC was found only in the subgroup > 65 years (adjusted HR: 1.292; 
95%CI: 1.033-1.615). The risk of UC in male patients with periodontitis was 
significantly higher than those without periodontitis (adjusted HR: 1.117; 95%CI: 
1.015–1.229), but not in females. Significantly increased risks of developing UC were 
detected in the periodontitis group among the subgroups with excessive alcohol 
drinking (adjusted HR: 1.593; 95%CI: 1.221-2.079), current smoking (adjusted HR: 
1.255; 95%CI: 1.079-1.461), and no regular exercise (adjusted HR: 1.205; 95%CI: 1.076-
1.349). Periodontitis did not significantly increase the risk of developing UC among the 
subpopulations with obesity and central obesity.
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Table 2 The incidence and risk for inflammatory bowel disease in patients with periodontitis
UC CD
n UC IR aHR (95%CI) CD IR aHR (95%CI)
Periodontitis
No 8857723 5224 7.1433 1 (ref.) 1300 1.7773 1 (ref.)
Yes 1092825 692 7.6730 1.091 (1.008-1.182) 126 1.3968 0.879 (0.731-1.057)
The incidence rate is represented by incident cases of ulcerative colitis or Crohn’s disease per 100000 person-years. The hazard ratio was adjusted for age, 
sex, body mass index, smoking, alcohol drinking, exercise, and income. UC: Ulcerative colitis; CD: Crohn’s disease; IR: Incidence rate; aHR: Adjusted 
hazard ratio; CI: Confidence intervals.
Figure 1  Cumulative incidence of ulcerative colitis in patients with and without periodontitis.
Risks of developing UC according to cigarette smoking behavior
We investigated the risks of developing UC in the periodontitis and non-periodontitis 
groups, respectively, according to smoking behavior (Figure 3). Ex-smokers in both 
groups had the highest risks of developing UC compared to nonsmokers without 
periodontitis, but the difference in the adjusted HRs between the periodontitis 
(adjusted HR: 1.667; 95%CI: 1.425-1.950) and non-periodontitis groups (adjusted HR: 
1.740; 95%CI: 1.606-1.884) among ex-smokers was not significant. However, current 
smokers in the periodontitis group (adjusted HR: 1.255; 95%CI: 1.078-1.462) had a 
significantly higher risk of developing UC, but not those in the non-periodontitis 
group (adjusted HR: 0.946; 95%CI: 0.874–1.025) compared to nonsmokers without 
periodontitis. A significant difference in adjusted HRs was observed between the 
periodontitis and non-periodontitis groups among current smokers (Figure 3A). The 
significant risk of developing UC in current smokers with periodontitis (adjusted HR: 
1.924; 95%CI: 1.197–3.092) was more pronounced in the elderly subgroup > 65 years 
than in nonsmokers without periodontitis (Figure 3B and C).
DISCUSSION
This population-based cohort study of approximately 10 million individuals reported 
that periodontitis significantly increased the risk of developing UC, but not CD, 
compared to those without periodontitis. The effect of periodontitis on the risk of 
developing UC was prominent, particularly among elderly male current smokers who 
drank alcohol and participated in reduced physical activity. In particular, current 
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Figure 2  Subgroup analysis of the comparative risk of ulcerative colitis and Crohn’s disease in patients with periodontitis compared with 
those without periodontitis. Error bars represent 95% confidence intervals. A: Ulcerative colitis; B: Crohn’s disease. HR: Hazard ratio; CI: Confidence interval.
smoking and the presence of periodontitis had a synergistic effect on the occurrence of 
UC in the elderly. To the best of our knowledge, this is the largest epidemiological 
study demonstrating the impact of periodontitis on the development of IBD based on 
demographic and environmental factors.
The risk for periodontitis among patients with IBD has been reported in recent 
studies[15,26-28]. In a matched-cohort study demonstrating the prevalence and relative 
risk of periodontitis, patients with CD were at a 1.36-fold increased risk for 
periodontitis than controls[29]. The relative risk of periodontitis is also significantly 
higher in patients with UC[30], especially in smokers[31], which suggests that 
periodontitis is an oral manifestation of IBD. Periodontitis may occur as a complication 
of IBD itself or as an adverse event related to IBD therapeutic agents. Changes in the 
host immune system in patients with a systemic disease may affect oral mucosal 
immunity. Subgingival microflora changes have been detected in patients with IBD 
and periodontitis[32], and dysregulation of the host immune system, such as in Th17 
cells and the interleukin (IL)-23/IL-17 axis have been proposed to be involved in the 
pathophysiology of periodontitis related to IBD[33].
In contrast, there is little evidence regarding the risk of developing IBD in patients 
with periodontitis. A Taiwanese cohort study reported a 1.56-fold significantly higher 
risk of UC, but not CD, in 27000 patients with periodontal diseases, including acute 
periodontitis, chronic periodontitis, and gingivitis[34], which is comparable with our 
results in a nationwide study of 1 million subjects with chronic periodontitis. Our 
study has the strength of demonstrating the impacts of chronic periodontitis, which 
may reflect the dynamics of chronic inflammatory conditions and lifestyle factors, such 
as cigarette smoking, on the pathogenesis of IBD. Taken together, the risk of 
developing UC increased significantly in patients with periodontitis, although the 
relatively low HR for UC in the periodontitis group needs to be evaluated by 
epidemiologic studies in other countries.
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Figure 3  The risk for developing ulcerative colitis with age and cigarette smoking behavior in the periodontitis and non-periodontitis 
groups. Error bars represent 95% confidence intervals. A: All ages; B: Age < 65; C: Age ≥ 65. HR: Hazard ratio.
The effect of periodontitis on the pathogenesis of UC may be associated with 
dysbiosis in the oral and intestinal microenvironments[35]. The role of the gut 
microbiota is critical in the pathogenesis of IBD in terms of nutrition, host immune 
response, and defense[36]. UC is associated with reduced microbial diversity and 
depletion of Bacteroidetes and Firmicutes in the gastrointestinal tract. Gut dysbiosis in 
IBD, particularly UC, is associated with changes in the salivary microbiome[37]. 
Therefore, oral hygiene and biofilms related to periodontitis might affect the initiation 
and perpetuation of inflammation via dysbiosis in the colon. In contrast, the dynamic 
interactions between the oral microenvironment and the development of intestinal 
inflammation in patients with CD are weak. In a recent population-based cohort study 
in Sweden, dental plaques were negatively associated with a 68% reduced risk of 
CD[38]. The dynamic impacts of oral hygiene on dysbiosis and chronic inflammation in 
the gastrointestinal tract should be clarified in further research.
We determined that the risk groups for UC related to periodontitis were elderly, 
male, alcohol drinking, current smoking, and reduced physical activity. These 
demographic and lifestyle factors that can alter oral hygiene have crucial effects on the 
development of UC among patients with periodontitis. Cigarette smoking may have a 
protective effect on the development of UC, while quitting smoking increases the risk 
of developing UC[39-42]. However, smoking and smoking cessation was not associated 
with disease course of UC[42]. Recent studies have demonstrated a dose-response 
relationship between quitting smoking and the risk of developing UC[11,43]. In line with 
previous results, ex-smokers had the highest risk of developing UC, regardless of the 
presence of periodontitis and age in this study. In contrast, current smoking effect on 
the prevention of UC is still controversial depending on subgroups such as ethnicity 
and gender. Interestingly, the comparative risk of developing UC in the elderly tended 
to be more pronounced in current smokers than in ex-smokers, suggesting that the 
synergistic effects of periodontitis and cigarette smoking increase the risk of elderly 
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onset UC. Cigarette smoking causes changes in both oral and intestinal microbial 
composition[44,45], and may play a key role as an environmental cause of UC via oral and 
gut dysbiosis. Cigarette smoking affects microbial diversity and composition resulting 
in decreases in Proteobacteria and Bacteroidetes and increases in Firmicutes[46]. A 
Treponema denticola infection is frequently detected in current smokers with 
periodontal disease[47]. Further research is needed to determine the combined effects of 
cigarette smoking and periodontitis on the pathogenesis of elderly onset UC, in terms 
of oral dysbiosis.
The incidence of UC shows a bimodal distribution in the age at onset[48-51], and the 
second peak of incidence in the elderly is closely related to the environmental 
etiologies of UC. Surprisingly, the age-specific incidence of UC is in a steady state 
between the ages of the 20 s to 60 s with the highest rates for men in their 60 s in a 
recent 30-year follow-up epidemiological study from South Korea[50]. The consistent 
evidence of ex-smokers related to the risk of UC development and the harmful 
synergistic effects of current cigarette smoking and periodontitis in the elderly provide 
an important clue to explain the role of environmental etiologies in the complex 
pathophysiology of elderly onset UC.
The present study had several limitations due to its retrospective design. First, the 
severity and disease extent of IBD could not be investigated. Second, the risk of 
developing IBD among patients with periodontitis was not adjusted by medication. 
Antibiotics are possible confounders in the relationship between periodontitis and IBD 
but are generally used within a short period in actual practice in this general 
population. It is assumed that the chaotic effects of antibiotics might be minimized 
considering the median follow-up period of more than 7 years. Use of corticosteroids 
and immunomodulatory agents could not be also identified due to the limitations of 
claims data. Third, the operational definition for the severity of periodontitis was not 
validated, although there was no significant difference in the comparative risk of 
developing UC based on the severity of periodontitis. Further prospective research is 
required to assess how the severity of periodontitis and oral dysbiosis affect the risk of 
developing UC.
CONCLUSION
Periodontitis was significantly associated with the risk of developing UC, but not CD. 
Current smoking superimposed the impacts of periodontitis on the occurrence of 
elderly onset UC. These findings suggest that adding cigarette smoking in the 
background of periodontitis are potential risk factors for elderly onset UC.
ARTICLE HIGHLIGHTS
Research background
Environmental factors in addition to genetic and immunological factors are known to 
influence on the development of inflammatory bowel disease (IBD) including Crohn’s 
disease (CD) and ulcerative colitis (UC). The effects of etiologies such as smoking, 
alcohol consumption, age and comorbidities on the occurrence of chronic intestinal 
inflammation may vary based on race and gender.
Research motivation
Gut dysbiosis is associated with IBD as a cause or result and is related to oral 
microflora. Oral disease can occur as an extra-intestinal manifestation of IBD. 
However, the risk of developing IBD in patients with periodontitis remains unclear.
Research objectives
We aimed to evaluate the risk of developing IBD in patients with periodontitis and to 
determine the combined effect of risk factors on the development of IBD associated 
with periodontitis.
Research methods
Using database of the National Health Insurance and National Health Screening 
Program in South Korea in 2009, we compared people with and without periodontitis 
and evaluated newly diagnosed IBD in both group during follow-up period until 2017. 
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All 9950548 people over the age of 20 who received a national health check in 2009 
were included. Periodontitis was defined using the International Classification of 
Disease 10th revision (ICD-10). CD and UC were defined using ICD-10 and rare 
intractable disease codes specific to South Korea.
Research results
Out of 9950548 individuals, a total of 1092825 subjects (11.0%) had periodontitis. The 
periodontitis group was older and had a higher male proportion. During the median 
follow-up period of 7.26 years, people with periodontitis had a significantly higher 
risk of developing UC than those without periodontitis. In a subgroup analysis, 
current smokers aged 65 and older with periodontitis had a 1.9-fold increase in UC 
risk than non-smokers aged 65 and older without periodontitis.
Research conclusions
Periodontitis is highly associated with the risk of developing UC, especially in current 
smokers over 65. It suggests that periodontitis and current smoking are a potential 
combined risk factor for the development of elderly-onset UC.
Research perspectives
Based on the results of this study, we need future prospective studies to focus on the 
synergistic impacts of the environmental risk factors on elderly onset UC in terms of 
complex interaction of oral and intestinal microflora. Ultimately, it can lead to a better 
understanding of the pathogenesis of IBD.
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